RhythMedix is the latest company to make moves in the space. The firm announced launching its next-generation wearable cardiac monitor that has built-in cellular connectivity.

The COVID-19 pandemic created a number of challenges, including cybersecurity risks. Ahead of the next crisis, medtech needs a proactive and inherent approach to cybersecurity.

Researchers fed a computer program with health data from 3,944 Danish COVID-19 patients to determine the mortality risk.

NASA is offering Fitbit devices to 1,000 mission-critical employees, including 150 astronauts, to mitigate the risk of spreading infectious disease among astronaut flight crews in the immediate preflight period.

The Mountain View, CA-based company won clearance from FDA for an expanded range of ECG determinations and had research with Mayo Clinic published in the peer-reviewed journal Circulation.

Reduced Medicare reimbursement rates is being cited as the main reason iRhythm's stock has tumbled, but is there more to the story than reimbursement?

The Marlborough, MA-based company has signed a multi-year agreement to integrate Google Cloud’s machine learning technologies with the Genius Digital System for the screening of cervical cancer.

Large medical device players are showing strong interest in the ambulatory ECG monitoring space. Here's a closer look at this industry trend.

J&J’s Depuy unit inherited Velys when it acquired Orthotaxy for an undisclosed sum in 2018.